Search Results | Grifols

Showing 504 search results

Filter by

Filter by

Refine your search

search_filters (Optional)

Contents

Files

News

search_filters-check

Reset filters Reset filters Apply

Sort by

Newest Oldest A-Z Z-A

Showing 504 search results

Grifols’ positive fibrinogen phase 3 trial results published in The Lancet’s eClinicalMedicine

June 19, 2025

Grifols successfully completes Biotest delisting

June 11, 2025

Anne-Catherine Berner, new Grifols Chair

June 5, 2025

Grifols celebrates 25^th anniversary of its Diagnostic R&D center in Bizkaia, a key driver of its sector leadership

May 29, 2025

Grifols receives FDA clearance of IND application for Phase 2 trial of immunoglobulin drops for dry eye disease

May 21, 2025

Grifols delivers strong results across the board, increasing revenues by 7.4%, Adj EBITDA by 14.2% and improving free cash flow by EUR 209m

May 12, 2025

Grifols partners with IBL International to develop advanced biomarker panels for unique clinical diagnostics platform

April 8, 2025

Grifols appoints Montse Ribas as Chief Communications and Reputation Officer to strengthen the company's global reputation

April 3, 2025

Grifols and Inpeco joining forces to deliver transfusion medicine ‘lab of the future’

March 20, 2025

Grifols Phase 2/3 trial shows positive impact of immunoglobulin therapy on post-polio patients

March 13, 2025

Grifols expects to reach EUR 10 billion in revenue, EUR 2.9 billion in EBITDA and EUR 3.5+ billion in cumulative cash flow by 2029

February 27, 2025

Grifols delivers a strong 2024 exceeding guidance on revenue and free cash flow

February 26, 2025

Show more results